Clinical trial · Observational
Robotic Radical Cystectomy Outcomes
Impact of Robotic Surgery on Post-operative Outcomes of Patients Who Underwent Radical Cystectomy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed appropriate and possible. The aim of the study is therefore the long-term evaluation of the peri-post-operative, oncological and functional results of patients undergoing radical cystectomy, both with an open and robotic approach. This study will thus help to clarify the actual impact of robotic surgery
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Muscle-Invasive Bladder Carcinoma | Muscle Invasive Bladder Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Oncology | — | UNRESOLVED | — |
| Recurrence | — | UNRESOLVED | — |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radical Cystectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Radical Cystectomy
- description
- Patients who underwent radical cystectomy for bladder cancer in our centre
- interventionNames
- Procedure: Radical Cystectomy
Primary outcomes (3)
- measure
- Number of participants who will die from bladder cancer
- timeFrame
- From enrollment to late follow-up, up to 7 years
- description
- Bladder Cancer Specific Mortality after surgery
- measure
- Number of participants who will experience bladder cancer recurrence
- timeFrame
- From enrollment to late follow-up, up to 7 years
- description
- Bladder Cancer Recurrence
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age major or equal 18 years * Patients who will undergo radical cystectomy * Consent to participate Exclusion Criteria: * Absence of willingness to participate * Further refusal to participate to the study
References
Publications (0)
Data not yet available